Table 2. Results of antimicrobial susceptibility testing.
| Antibiotic disk | µg/disc | Zone diameter (mm) |
|||
|---|---|---|---|---|---|
| Inhibition circle | Resistance | Intermedium | Susceptive | ||
| Penicillin (PCG) | 10 | 6 | 14 | 15 | |
| Ampicillin (ABPC) | 10 | 6 | 13 | 14–16 | 17 |
| Amoxicillin (AMPC) | 25 | 6 | 14 | 15–20 | 21 |
| Cefazolin (CEZ) | 30 | 23 | 19 | 20–22 | 23 |
| Cefuroxime (CXM) | 30 | 22 | 14 | 15–17 | 18 |
| Cefotaxime (CTX) | 30 | 32 | 22 | 23–25 | 26 |
| Cefoxitin (CFX) | 30 | 23 | 14 | 15–17 | 18 |
| Fosfomycin (FOM) | 50 | 11 | 12 | 13–15 | 16 |
| Streptomycin (SM) | 300 | 6 | 11 | 12–14 | 15 |
| Gentamicin (GM) | 120 | 21 | 12 | 13–14 | 15 |
| Kanamycin (KM) | 30 | 22 | 13 | 14–17 | 18 |
| Azithromycin (AZM) | 15 | 13 | 13 | 14–22 | 23 |
| Erythromycin (EM) | 15 | 11 | 13 | 14–22 | 23 |
| Tetracycline (TC) | 30 | 7 | 11 | 12–14 | 15 |
| Oxytetracycline (OTC) | 30 | 6 | 14 | 15–18 | 19 |
| Florfenicol (FF) | 30 | 24 | 14 | 15–18 | 19 |
| Clindamycin (CM) | 2 | 7 | 14 | 15–20 | 21 |
| Sulfamethoxazole/Trimethoprim (ST) | 23.75/1.25 | 23 | 10 | 11–15 | 16 |
| Nalidixic acid (NA) | 30 | 24 | 13 | 14–18 | 19 |
| Ciprofloxacin (CPFX) | 5 | 28 | 15 | 16–20 | 21 |
| Norfloxacin (NRFX) | 10 | 27 | 12 | 13–16 | 17 |